1-7 of 7
James L. Abbruzzese
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract C26: Development and validation of a scoring system using insulin-like growth factor to assess hepatic reserve in hepatocellular carcinoma.

Ahmed O. Kaseb, Lianchun Xiao, Rania Naguib, Wafaa El-Shikh, Manal Hassan, Hesham Hassabo, Jeong-Hoon Lee, Jung-Hwan Yoon, Hyo-Suk Lee, Young Kwang Chae, James L. Abbruzzese, Jeffrey Morris
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): C26.
https://doi.org/10.1158/1535-7163.TARG-13-C26
Published: 01 November 2013
View article titled, Abstract C26: Development and validation of a scoring system using insulin-like growth factor to assess hepatic reserve in hepatocellular carcinoma.
Journal Articles

Abstract B101: Design and optimization of a new series of HSP70 inhibitors for use in the treatment of pancreatic cancer.

David S. Maxwell, Duoli Sun, Zhenghong Peng, Wei Qi, David McConkey, James L. Abbruzzese, William G. Bornmann
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): B101.
https://doi.org/10.1158/1535-7163.TARG-13-B101
Published: 01 November 2013
View article titled, Abstract B101: Design and optimization of a new series of HSP70 inhibitors for use in the treatment of pancreatic cancer.
Journal Articles

Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression

Santhi Konduri, Jimmie Colon, Cheryl H. Baker, Stephen Safe, James L. Abbruzzese, Ala Abudayyeh, Md. Riyaz Basha, Maen Abdelrahim
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (3): 533–542.
https://doi.org/10.1158/1535-7163.MCT-08-0405
Published: 13 March 2009
View article titled, Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression
Open the PDF for Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression in another window
Includes: Supplementary data
Journal Articles

LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis

Davide Melisi, Satoshi Ishiyama, Guido M. Sclabas, Jason B. Fleming, Qianghua Xia, Giampaolo Tortora, James L. Abbruzzese, Paul J. Chiao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (4): 829–840.
https://doi.org/10.1158/1535-7163.MCT-07-0337
Published: 15 April 2008
View article titled, LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
Open the PDF for LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis in another window
Includes: Supplementary data
Journal Articles

Nuclear factor-κB maintains TRAIL resistance in human pancreatic cancer cells

Sanaz Khanbolooki, Steffan T. Nawrocki, Thiruvengadam Arumugam, Robert Andtbacka, Maria S. Pino, Razelle Kurzrock, Craig D. Logsdon, James L. Abbruzzese, David J. McConkey
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (9): 2251–2260.
https://doi.org/10.1158/1535-7163.MCT-06-0075
Published: 19 September 2006
View article titled, Nuclear factor-κB maintains TRAIL resistance in human pancreatic cancer cells
Open the PDF for Nuclear factor-κB maintains TRAIL resistance in human pancreatic cancer cells in another window
Journal Articles

Effects of the Proteasome Inhibitor PS-341 on Apoptosis and Angiogenesis in Orthotopic Human Pancreatic Tumor Xenografts

Steffan T. Nawrocki, Christiane J. Bruns, Matthew T. Harbison, Richard J. Bold, Bridget Sweeney Gotsch, James L. Abbruzzese, Peter Elliott, Julian Adams, David J. McConkey
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2002) 1 (14): 1243–1253.
Published: 01 December 2002
View article titled, Effects of the Proteasome Inhibitor PS-341 on Apoptosis and Angiogenesis in Orthotopic Human Pancreatic Tumor Xenografts
Open the PDF for Effects of the Proteasome Inhibitor PS-341 on Apoptosis and Angiogenesis in Orthotopic Human Pancreatic Tumor Xenografts in another window
Journal Articles

Preclinical and Clinical Pharmacodynamic Assessment of L-778,123, a Dual Inhibitor of Farnesyl:Protein Transferase and Geranylgeranyl:Protein Transferase Type-I

Robert B. Lobell, Dongming Liu, Carolyn A. Buser, Joseph P. Davide, Elizabeth DePuy, Kelly Hamilton, Kenneth S. Koblan, Yih Lee, Scott Mosser, Sherri L. Motzel, James L. Abbruzzese, Charles S. Fuchs, Eric K. Rowinsky, Eric H. Rubin, Sunil Sharma, Paul J. Deutsch, Kathryn E. Mazina, Briggs W. Morrison, Lynne Wildonger, Siu-Long Yao, Nancy E. Kohl
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2002) 1 (9): 747–758.
Published: 01 July 2002
View article titled, Preclinical and Clinical Pharmacodynamic Assessment of L-778,123, a Dual Inhibitor of Farnesyl:Protein Transferase and Geranylgeranyl:Protein Transferase Type-I
Open the PDF for Preclinical and Clinical Pharmacodynamic Assessment of L-778,123, a Dual Inhibitor of Farnesyl:Protein Transferase and Geranylgeranyl:Protein Transferase Type-I in another window